Skip to main content
. 2020 Dec 31;13(1):114. doi: 10.3390/cancers13010114

Table 1.

Characterisation of the PitNET TMA cohort, including TGFBR3L.

Tumour Type Number IHC Subtype Clinical Phenotype TGFBR3L Positive
Gonadotroph 110 SF1; FSH/LH NF-PitNET 1 37
Corticotroph 21 T-Pit; ACTH Cushing/Nelson 0
25 T-Pit; ACTH NF-PitNET 1 0
Somatotroph 24 Pit-1; GH Acromegaly 0
31 Pit-1; GH-PRL Acromegaly 0
2 Pit-1; GH NF-PitNET 1 0
Lactotroph 6 Pit-1; PRL Hyperprolactinemia 0
2 Pit-1; PRL NF-PitNET 1 0
Thyrotroph 2 Pit-1; TSH HyperTSH 0
Null cell 7 TFs 2 neg;
Hormone neg.
NF-PitNET 1 0
Total 230 37

1 NF-PitNet: Non-functioning pituitary neuroendocrine tumour. 2 TF: Transcription factor.